Chemoinformaics analysis of P-METHOXYCINNAMALDEHYDE
Molecular Weight | 162.188 | nRot | 3 |
Heavy Atom Molecular Weight | 152.108 | nRig | 8 |
Exact Molecular Weight | 162.068 | nRing | 1 |
Solubility: LogS | -2.354 | nHRing | 0 |
Solubility: LogP | 2.244 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 24.9719 |
nHD | 0 | BPOL | 12.6361 |
QED | 0.501 |
Synth | 1.918 |
Natural Product Likeliness | 0.673 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.01 |
CACO-2 | -4.529 |
MDCK | 0.0000187 |
BBB | 0.987 |
PPB | 0.880058 |
VDSS | 1.435 |
FU | 0.0892425 |
CYP1A2-inh | 0.961 |
CYP1A2-sub | 0.92 |
CYP2c19-inh | 0.493 |
CYP2c19-sub | 0.784 |
CYP2c9-inh | 0.095 |
CYP2c9-sub | 0.903 |
CYP2d6-inh | 0.029 |
CYP2d6-sub | 0.914 |
CYP3a4-inh | 0.024 |
CYP3a4-sub | 0.33 |
CL | 6.763 |
T12 | 0.723 |
hERG | 0.078 |
Ames | 0.899 |
ROA | 0.747 |
SkinSen | 0.963 |
Carcinogencity | 0.751 |
EI | 0.989 |
Respiratory | 0.954 |
NR-Aromatase | 0.017 |
Antiviral | No |
Prediction | 0.88226 |